Bill Text: DE SCR73 | 2015-2016 | 148th General Assembly | Draft
Bill Title: Continuing To Raise Awareness That The Month Of May Is Melanoma And Skin Cancer Detection And Prevention Month In Delaware And Lauding A New Treatment For Advanced Melanoma.
Sponsorship: Broadly Bipartisan Bill
Status: (Engrossed - Dead) 2016-05-04 - Passed in House by Voice Vote [SCR73 Detail]
Download: Delaware-2015-SCR73-Draft.html
|
SPONSOR: |
Sen. Cloutier & Sen. Hall-Long & Sen. McDowell & Rep. Schwartzkopf |
|
Sens. Blevins, Bushweller, Ennis, Hocker, Lavelle, Lopez, Peterson, Pettyjohn, Richardson; Reps. Baumbach, Briggs King, Dukes, Heffernan, Hudson, Jaques, Q. Johnson, Kenton, Kowalko, Miro, Mitchell, Osienski, Outten, B. Short, D. Short, M. Smith, Spiegelman, K. Williams, Wilson |
|
DELAWARE STATE SENATE 148th GENERAL ASSEMBLY |
|
SENATE CONCURRENT RESOLUTION NO. 73 |
|
CONTINUING TO RAISE AWARENESS THAT THE MONTH OF MAY IS MELANOMA AND SKIN CANCER DETECTION AND PREVENTION MONTH IN DELAWARE AND LAUDING A NEW TREATMENT FOR ADVANCED MELANOMA. |
WHEREAS, since 2009, May has been permanently designated in the Delaware Code as Melanoma and Skin Care Cancer Detection and Prevention Month in Delaware; and
WHEREAS, it continues to be important to raise awareness of this too often deadly form of cancer; and
WHEREAS, exposure to ultraviolet rays is the most significant environmental factor which leads to cancer; and
WHEREAS, melanoma is curable if detected and treated in its early stages; and
WHEREAS, melanoma accounts for only one percent of all skin cancer cases, but the vast majority of skin cancer related deaths; and
WHEREAS, skin cancer in general affects one in five Americans, resulting in more than 5.4 million new cases diagnosed each year; and
WHEREAS, melanoma incidence rates have been increasing for at least 30 years; and
WHEREAS, there is approximately a 2% annual increase in the number of melanoma cases each year; and
WHEREAS, there is estimated to be 10,130 melanoma related deaths this year; and
WHEREAS, the American Cancer Society estimates that in 2016 there will be 320 newly diagnosed cases of melanoma in Delaware and 76,380 newly diagnosed cases of melanoma nationally; and
WHEREAS, May is recognized across the United States as National Melanoma and Skin Cancer Detection and Prevention Month; and
WHEREAS, talimogene laherparepvec is the first oncolytic virus immunotherapy, a new class of treatments that use genetically engineered viruses to preferentially kill cancer cells;
WHEREAS, this treatment is the result of American scientific ingenuity and persistence, represents the possibility of future developments for immunotherapies, and will save the lives of many melanoma patients in years to come;
NOW THEREFORE:
BE IT RESOLVED by the Senate of the 148th General Assembly of the State of Delaware, the House concurring therein, that there is a continuing need to raise awareness that the month of May is Melanoma and Skin Cancer Detection and Prevention Month in Delaware.
BE IT FURTHER RESOLVED that the General Assembly lauds talimogene laherparepvec, which was approved by the Food and Drug Administration on October 27, 2015 and is the first in a new class of immunotherapies for the treatment of advanced melanoma.
SYNOPSIS
|
This Resolution continues to raise awareness that the month of May is Melanoma and Skin Cancer Detection and Prevention Month in Delaware and lauds a new treatment for advanced melanoma. |
AUTHOR:Sen. Cloutier
